Audrey Rhee

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Prognosis of Mucinous Adenocarcinoma of the Prostate Treated by Radical Prostatectomy

Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy

Nomograms in oncology: more than meets the eye

Nutrition and physical activity guidelines for cancer survivors

Epidemiology of Prostate Cancer

Platelet Count and Preoperative Haemoglobin Do Not Significantly Increase the Performance of Established Predictors of Renal Cell Carcinoma-Specific Mortality

Insulin and insulin-like growth factor signalling in neoplasia

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution

Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

The JAK/STAT signaling pathway: from bench to clinic

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle‐aged men

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy

Mucinous adenocarcinoma of the prostate does not confer poor prognosis

Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

How To Build and Interpret a Nomogram for Cancer Prognosis

Diabetes and Cancer

Energetics in Colorectal and Prostate Cancer

Guideline for Management of the Clinical T1 Renal Mass

Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy

Weight Gain Is Associated with an Increased Risk of Prostate Cancer Recurrence after Prostatectomy in the PSA Era

Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)

Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy

Mucinous adenocarcinoma of the prostate: a case report of long-term disease-free survival and a review of the literature

Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production

796: Surgeon Volume is Predictor of Improved Outcomes in Radical Prostatectomy Patients